Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be reporting results this Thursday before market open.

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

The market expects Collegium Pharmaceutical (COLL) to deliver a year-over-year increase in earnings on higher revenues when ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds.

There are basically three ways students can earn COLL 300 credit: If you want to offer a COLL 300 opportunity of type 1, you do not need to seek EPC approval. Students who earn at least 3 credits in ...